CLOs on the Move

TCP Reliable

www.tcpreliable.com

 
TCP Reliable is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. TCP Reliable is based in Edison, NJ. You can find more information on TCP Reliable at www.tcpreliable.com
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Iroquois Nursing Home

Iroquois Nursing Home is a Jamesville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elementis Specialties (RHEOX)

Elementis Specialties (RHEOX) is a Hightstown, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

PreferredOne

At PreferredOne, our name says it all. You, our valued members, are our preferred ones. Everything we do is for one purpose - to make your experience the best it can be.   We offer individual health insurance, family medical plans and group health insurance to fit your needs and budget, plus wellness programs to help you stay healthy. We are known for outstanding customer service and for paying claims promptly, and our representatives are available to answer any questions you have about health care coverage.   PreferredOne has served our Minnesota and upper Midwest members for almost 30 years.

Mid Coast Health Services

Mid Coast Health Services is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Mid Coast Health Services is based in Brunswick, ME. You can find more information on Mid Coast Health Services at www.midcoasthealth.com

Dimension Therapeutics

Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.